Searched for
TRUST MUTUAL FUNDS
BSE subsidiary ICCL adopts new brand identity as BSE ClearingThe company said the transition marks a significant milestone in strengthening alignment with parent entity BSE Ltd and reinforces its role...- HealthQuad raises Rs 550 crore, eyes Rs 1,700 crore fundHealthQuad has secured Rs 550 crore for its third fund. The venture capital firm aims to raise Rs 1,700 crore to back early-growth companie...
- HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block dealSepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged...
- How Life Cycle Funds aim to simplify long-term wealth creationIndian mutual fund houses are launching Life Cycle Funds, a new goal-based investment product. These funds automatically adjust asset alloc...
- InvIT market expands with new listings; cumulative distributions top Rs 91,000 croreIndia’s InvIT sector recorded strong growth in FY26, with Rs 7,719 crore distributed in Q4 alone and cumulative payouts crossing Rs 91,000 ...
- India's REIT and InvIT market to attract Rs 11.6 trillion new investments; AUM may double to Rs 20 trillion by 2030: Avendus CapitalIndia’s REIT and InvIT market could attract an additional Rs 11.6 trillion in investments by 2030, taking total assets under management bey...
- From bombs to billions: The strange economics of US-Iran peace dealIran and United States are set to sign a peace deal involving significant financial concessions and sanctions relief for Iran. The deal see...
- PMS vs mutual funds: 5 reasons to invest, and 5 red flags to watchPortfolio Management Services (PMS) offer structural advantages over mutual funds, allowing for concentrated portfolios, significant cash h...
- Lenskart block deal; Meesho's kirana pushLenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.
- ET Alpha Wealth Summit | BSE CEO Sundararaman Ramamurthy on building trust, fighting deepfakes, and why yuva shakti & nari shakti are future of D-StBSE MD & CEO Sundararaman Ramamurthy highlighted India's market evolution from uncertain settlements to a trust-based system, driven by tec...
- Lenskart shares in focus as Goldman Sachs, Morgan Stanley, others purchase stake in Rs 1,960 crore block dealLenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...
- Goldman Sachs, Morgan Stanley and others buy stake in Rs 1,960 crore Lenskart block dealADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...
- Block deal: Goldman Sachs picks stake in this smallcap stock that surged 50% in 6 monthsGNG Electronics witnessed a Rs 175 crore block deal as promoter Vidhi Khandelwal sold shares to domestic mutual funds and foreign investors...
- Lenskart Solutions sees Rs 1,862-crore block deal; ADIA likely sellerEyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...
- No individual data, Sebi to tweak AMC exec pay disclosure normsIn a bold initiative, the Securities and Exchange Board of India (Sebi) is looking to overhaul the reporting standards for executive compen...
- ADIA to sell Rs 1,944 crore Lenskart stake days after SoftBank exitAbu Dhabi Investment Authority (ADIA) is set to divest up to 2.3% of its stake in eyewear retailer Lenskart for approximately Rs 1,944 cror...
- Nuvama Wealth receives final SEBI approval to launch mutual fund businessNuvama Wealth Management has received final Sebi approval to enter the mutual fund business through Nuvama Asset Management. The company pl...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- Portfolio management services explained: How PMS works, its types, costs, and who should investIf you are confused by personal finance terms, jargon and calculations, here’s a series to simplify and deconstruct these for you. In the 1...
Load More
